Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
VENPACE is a venture capital organization based in Cologne, Germany, founded in 2020. The firm focuses on developing digital business models specifically for the insurance industry. By investing in innovative ideas within this market, VENPACE aims to address the unique challenges faced by startups in the insurtech sector. The firm is dedicated to the DACH region, which includes Germany, Austria, and Switzerland, and seeks to foster sustainable scaling of startups through both capital investment and access to industry resources.
Currently, VENPACE manages a portfolio of nine companies, reflecting its commitment to supporting early-stage ventures. The firm collaborates with various insurance companies, providing its portfolio companies with direct access to distribution channels and partnership opportunities. This operational model is bolstered by a team of four professionals who leverage their deep connections within the insurance industry to facilitate growth for their startups.
Notable milestones for VENPACE include its establishment as a specialist fund focused on insurtech, which has allowed it to carve out a niche in the European venture capital landscape. The firm’s approach combines financial backing with strategic industry insights, making it a valuable partner for startups aiming to innovate within the insurance sector.
VENPACE primarily invests in startups within the insurtech sector, specifically targeting companies in the Pre-Seed and Seed stages. The firm’s investment strategy is centered around identifying challenges and opportunities within the insurance industry, which allows them to develop innovative business models that address these issues. By collaborating with partners, VENPACE helps establish these models as viable startups, ensuring they are well-positioned for growth.
The firm’s check sizes and specific fund sizes are not publicly disclosed, but its focus on early-stage investments suggests a commitment to nurturing nascent ideas. VENPACE emphasizes the importance of sustainable scaling, which indicates that they look for startups that not only have innovative solutions but also a clear path to growth and market penetration. Their geographic focus on the DACH region allows them to leverage local market knowledge and connections, enhancing their ability to support portfolio companies effectively.
VENPACE’s thesis revolves around tackling the insurance industry's challenges by developing and establishing innovative business models. This focus on insurtech positions them uniquely within the venture capital space, as they provide more than just capital; they offer access to a network of industry connections, pilot opportunities, and built-in sales channels into major insurance carriers.
VENPACE's portfolio consists of nine companies, each addressing specific needs within the insurance and fintech sectors. The following are notable portfolio companies:
These companies reflect VENPACE's commitment to supporting innovative solutions in the insurance sector, with a focus on enhancing operational efficiencies and customer experiences.
Crossbuilders Team: This team is responsible for startups and venture management at VENPACE. They bring extensive experience in the insurance industry and venture capital, facilitating the growth of portfolio companies through strategic guidance and industry connections.
To pitch to VENPACE, founders should visit their website at venpace.com. The firm prefers direct applications through their online platform. When preparing a pitch deck, it is important to include a clear overview of the business model, market analysis, and the team’s qualifications. Founders should also outline their growth strategy and how they plan to address challenges in the insurance sector.
Response times may vary, but founders can expect to hear back regarding their applications. Warm introductions are beneficial, as they can enhance the likelihood of securing a meeting with the investment team.
As of March 2023, VENPACE has been actively investing in innovative insurtech startups, maintaining a portfolio of nine companies. Recent investments include companies such as DC Connected Car and HealthCaters, which focus on various aspects of the insurance and healthcare sectors. The firm continues to strengthen its presence in the DACH region, with a focus on fostering digital business models within the insurance industry.
What are VENPACE's investment criteria?
VENPACE invests in startups within the insurtech sector, specifically targeting companies in the Pre-Seed and Seed stages. They look for innovative business models that address challenges in the insurance industry.
How can I apply or pitch to VENPACE?
Founders can pitch their ideas by visiting the VENPACE website at venpace.com. The firm encourages direct applications through their online platform.
What makes VENPACE different from other venture capital firms?
VENPACE differentiates itself by providing not only capital but also access to a network of insurance industry connections, enabling partnerships and pilot opportunities for startups.
What is VENPACE's geographic scope?
VENPACE primarily focuses on the DACH region, which includes Germany, Austria, and Switzerland, allowing them to leverage local market knowledge and connections.
What is VENPACE's post-investment involvement like?
VENPACE actively supports its portfolio companies by facilitating access to industry resources, partnerships, and built-in sales channels into major insurance carriers.
What is the typical check size for investments?
Specific check sizes are not publicly disclosed, but VENPACE focuses on early-stage investments, indicating a commitment to supporting nascent ideas with appropriate funding.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.